We are monitoring the impact of COVID-19 on Europe Biomarkers Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 166
Share on
Share on

Europe Biomarkers Market Research Report – segmented By Product, Type, Disease Indications & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) – Analysis on Size, Share, Trends, Growth, Forecast | 2020 to 2025

Pulished: February, 2020
ID: 166
Pages: 145

Europe Biomarkers Market Size (2020 to 2025)

The size of the biomarkers market in the European market is expected to reach USD 19.07 billion by 2025 from USD 10.39 billion in 2020, growing at a CAGR of 12.90% during the forecast period.

Biomarkers are described as the biological molecules or genes that assist in crucial clinical decisions and diagnosis of health conditions in patients. These are also known as molecular markers or signature molecules and used to analyze the pharmacologic responses, biological & pathological conditions. Biomarkers are found extensively in body fluids and tissues. Biomarkers are helpful in drug discovery & development processes and assessment of disease conditions.

Increasing healthcare expenditure, growing the aging population, rising number of cancer patients, increasing demand for diagnostics, raising awareness on healthy lifestyles are driving the growth of the biomarkers market in Europe. Besides, the rising utilization of biomarkers in clinical trials & drug discovery and growing technologies in biomarkers discovery is further stimulating the growth of the biomarkers market in Europe.

However, the requirement of qualitative biomarkers validation and the high cost of the development of the biomarkers are expected to restrain the growth of the biomarkers market in Europe.

This research report segmented and sub-segmented into the following categories:

  • By Product: Consumables, Services, Software & Growth Hormone Therapy
  • By Type: Safety Biomarkers, Efficacy Biomarkers & Validation Biomarkers
  • By Application: Diagnostics Development, Drug Discovery, and Development, Personalised Medicine, Disease Risk Assessment & Other Applications.
  • By Disease Indications: Cancer, Cardiovascular Disorders, Neurological disorders, Immunological Disorders & Other Diseases
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Top companies in this market

Companies dominating the European Biomarkers Market profiled in this report are Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Enzo Biochem (U.S.), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), EKF Diagnostics Holdings plc. (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France) and Signosis, Inc. (U.S.)

 

  1. Introduction

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

  1. Market Segmentation

                5.1          Product                                               

                                5.1.1 Introduction                                           

                                5.1.2 Consumables                                         

                                5.1.3 Software                                  

                                5.1.4 Services     Growth Hormone Therapy                         

                5.2          Type                                     

                                5.2.1 Introduction                                           

                                5.2.2 Safety Biomarkers                                               

                                5.2.3 Efficacy Biomarkers                                             

                                5.2.4 Validation Biomarkers                                        

                5.3          Application                                        

                                5.3.1 Introduction                                           

                                5.3.2 Diagnostics Development                                 

                                5.3.3 Drug Discovery and Development                                

                                5.3.4 Personalised Medicine                                      

                                5.3.5 Disease Risk Assessment                                  

                                5.3.6 Other Applications                                               

                5.4          Disease Indications                                        

                                5.4.1 Introduction                                           

                                5.4.2 Cancer                                      

                                5.4.3 CardiovascularDisorders                                    

                                5.4.4 Neurological Disorders                                       

                                5.4.5 Immunological Disorders                                  

                                5.4.6 Other Diseases                                      

  1. Geographical Analysis

                                6.1 Introduction                                               

                                6.2 U.K                                 

                                6.3 Spain                                             

                                6.4 Germany                                     

                                6.5 Italy                                               

                                6.6 France                                          

  1. Strategic Analysis

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

  1. Market Leaders' Analysis

                8.1 Bio-Rad Laboratories (U.S.)                                 

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Qiagen N.V. (Netherlands)                                  

                8.3 Enzo Biochem (U.S.)                                               

                8.4 PerkinElmer, Inc. (U.S.)                                         

                8.5 Merck & Co, Inc. (U.S.)                                          

                8.6 EKF Diagnostics Holdings plc. (U.S.)                                  

                8.7 Meso Scale Diagnostics, LLC (U.S.)                                    

                8.8 Singulex, Inc. (U.S.)                                 

                8.9 BioSims Technologies (France)                                           

                8.10 Cisbio Bioassays (France)                                   

                8.11 Signosis, Inc. (U.S.)                                               

  1. Competitive Landscape

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

     Appendix                                                                           

  1. List of Tables
  2. List of Figures
  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Europe Biomarkers Market By Region, From 2020 to 2025 (USD Billion)
  2. Europe Biomarkers Market By Product, From 2020 to 2025 (USD Billion)
  3. Europe Consumables Market By Region, From 2020 to 2025 (USD Billion)
  4. Europe Software Market By Region, From 2020 to 2025 (USD Billion)
  5. Europe Services Market By Region, From 2020 to 2025 (USD Billion)
  6. Europe Biomarkers Market By Type, From 2020 to 2025 (USD Billion)
  7. Europe Safety Biomarkers Market By Region, From 2020 to 2025 (USD Billion)
  8. Europe Efficacy Biomarkers Market By Region, From 2020 to 2025 (USD Billion)
  9. Europe Validation Biomarkers Market By Region, From 2020 to 2025 (USD Billion)
  10. Europe Biomarkers Market By Application, From 2020 to 2025 (USD Billion)
  11. Europe Diagnostics Development Market By Region, From 2020 to 2025 (USD Billion)
  12. Europe Drug Discovery and Development Market By Region, From 2020 to 2025 (USD Billion)
  13. Europe Personalised Medicine Market By Region, From 2020 to 2025 (USD Billion)
  14. Europe Disease Risk Assessment Market By Region, From 2020 to 2025 (USD Billion)
  15. Europe Other Applications Market By Region, From 2020 to 2025 (USD Billion)
  16. Europe Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Billion)
  17. Europe Cancer Market By Region, From 2020 to 2025 (USD Billion)
  18. Europe Cardiovascular Disorders Market By Region, From 2020 to 2025 (USD Billion)
  19. Europe Neurological Disorders Market By Region, From 2020 to 2025 (USD Billion)
  20. Europe Immunological Disorders Market By Region, From 2020 to 2025 (USD Billion)
  21. Europe Other Diseases Market By Region, From 2020 to 2025 (USD Billion)
  22. U.K. Biomarkers Market By Product, From 2020 to 2025 (USD Billion)
  23. U.K. Biomarkers Market By Type, From 2020 to 2025 (USD Billion)
  24. U.K. Biomarkers Market By Application, From 2020 to 2025 (USD Billion)
  25. U.K. Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Billion)
  26. Germany Biomarkers Market By Product, From 2020 to 2025 (USD Billion)
  27. Germany Biomarkers Market By Type, From 2020 to 2025 (USD Billion)
  28. Germany Biomarkers Market By Application, From 2020 to 2025 (USD Billion)
  29. Germany Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Billion)
  30. France Biomarkers Market By Product, From 2020 to 2025 (USD Billion)
  31. France Biomarkers Market By Type, From 2020 to 2025 (USD Billion)
  32. France Biomarkers Market By Application, From 2020 to 2025 (USD Billion)
  33. France Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Billion)
  34. Italy Biomarkers Market By Product, From 2020 to 2025 (USD Billion)
  35. Italy Biomarkers Market By Type, From 2020 to 2025 (USD Billion)
  36. Italy Biomarkers Market By Application, From 2020 to 2025 (USD Billion)
  37. Italy Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Billion)
  38. Spain Biomarkers Market By Product, From 2020 to 2025 (USD Billion)
  39. Spain Biomarkers Market By Type, From 2020 to 2025 (USD Billion)
  40. Spain Biomarkers Market By Application, From 2020 to 2025 (USD Billion)
  41. Spain Biomarkers Market By Disease Indications, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample